跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 19, 2022
Approval ID
fb1625a51ef1139b
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
fb1625a51ef1139b
Drug Cima Aemps Name
VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number
88218
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2022-10-19
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
6 mg/0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
TAMSULOSINA HIDROCLORURO
0,4 mg
SOLIFENACINA SUCCINATO
6 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 19, 2022
Approval ID
fb1625a51ef1139b
Type
Standard
Back to CIMA-AEMPS Approvals
VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details